Randomised trials at the level of the individual

Jay J.H. Park, Nathan Ford, Denis Xavier, Per Ashorn, Rebecca F. Grais, Zulfiqar A. Bhutta, Herman Goossens, Kristian Thorlund, Maria Eugenia Socias, Edward J. Mills

Research output: Contribution to journalReview articlepeer-review

9 Citations (Scopus)


In global health research, short-term, small-scale clinical trials with fixed, two-arm trial designs that generally do not allow for major changes throughout the trial are the most common study design. Building on the introductory paper of this Series, this paper discusses data-driven approaches to clinical trial research across several adaptive trial designs, as well as the master protocol framework that can help to harmonise clinical trial research efforts in global health research. We provide a general framework for more efficient trial research, and we discuss the importance of considering different study designs in the planning stage with statistical simulations. We conclude this second Series paper by discussing the methodological and operational complexity of adaptive trial designs and master protocols and the current funding challenges that could limit uptake of these approaches in global health research.

Original languageEnglish
Pages (from-to)e691-e700
JournalThe Lancet Global Health
Issue number5
Publication statusPublished - May 2021


Dive into the research topics of 'Randomised trials at the level of the individual'. Together they form a unique fingerprint.

Cite this